Provided by Tiger Trade Technology Pte. Ltd.

Lands' End

11.97
+0.14461.22%
Volume:52.28K
Turnover:621.07K
Market Cap:368.23M
PE:1.08
High:12.12
Open:11.74
Low:11.51
Close:11.83
52wk High:20.04
52wk Low:9.56
Shares:30.75M
Float Shares:11.75M
Volume Ratio:0.95
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.07
EPS(LYR):0.1796
ROE:94.21%
ROA:2.76%
PB:0.73
PE(LYR):66.69

Loading ...

Largest borrow rate increases among liquid names

TIPRANKS
·
Apr 02

Lands’ End launches USD 100 million share buyback program through March 2029

Reuters
·
Apr 01

Lands' End Board Authorizes $100 Million Share Repurchase Program

THOMSON REUTERS
·
Apr 01

Lands’ End, WHP Global form joint venture, Lands’ End gets $300 million for 50% stake

Reuters
·
Apr 01

Whp Global Announces Expiration of Lands' End Tender Offer

THOMSON REUTERS
·
Apr 01

Press Release: WHP Global Announces Expiration of Lands' End Tender Offer

Dow Jones
·
Apr 01

Lands’ End announces annual stockholders meeting; FY2025 adjusted EBITDA rises to $102.3 million

Reuters
·
Mar 28

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

Dow Jones
·
Mar 20

Lands' End Price Target Maintained With a $45.00/Share by Small Cap Consumer Research

Dow Jones
·
Mar 20

Lands' End 4Q Profit Falls Due to Tariff Costs

Dow Jones
·
Mar 19

Lands’ End Q4 FY2025 adjusted net income rises 33.2% to USD 23.57 million on net revenue up 4.7% to USD 462.37 million

Reuters
·
Mar 19

Lands' End Q4 Adj. EPS $0.76 Misses $0.77 Estimate, Sales $462.372M Miss $471.005M Estimate.

Benzinga Earnings
·
Mar 19

Lands' End Inc: Due to Pending Transaction With Whp Global, Co Will Not Be Providing Financial Guidance at This Time

THOMSON REUTERS
·
Mar 19

Lands' End Inc expected to post earnings of 77 cents a share - Earnings Preview

Reuters
·
Mar 17

Lands’ End approves transaction success bonuses up to 2x base salary for executives

Reuters
·
Mar 12

Lands' End Price Target Maintained With a $45.00/Share by Small Cap Consumer Research

Dow Jones
·
Mar 11

Press Release: Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 10